JPRN-UMIN000007504已完成1 期
Phase I study of peptides derived from novel cancer antigen using with Gemcitabine for advanced pancreatic cancer - Phase I study of peptides derived from novel cancer antigen using with Gemcitabine for advanced pancreatic cancer
YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology0 个研究点目标入组 18 人开始时间: 2012年3月17日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. pregnant woman 2. 3. 4. 5. Steroid or immunosuppressive therapy 6. 7. 8.Doctors opinion
研究者
相似试验
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines targeting VEGFR1 in patients with advanced renal cell carcinomaadvanced renal cell carcinomaJPRN-UMIN000004911Department of Urology, Kinki University School of Medicine18
已完成
1 期
Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.unresectable colorectal cancerJPRN-UMIN000000956Institute of Medical Science The University of Tokyo6
已完成
2 期
Phase II Study of Combination Epitope Peptides for Advanced/metastatic Pancreatic CancerAdvanced/metastatic Pancreatic CancerJPRN-UMIN000007505YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE Department of Digestive Surgery and Surgical Oncology50
已完成
1 期
Phase I/II study of a novel peptide vaccination therapy, CDCA1 and KOC1, for previously treated advanced non-small-cell lung cancerpreviously treated advanced non-small-cell lung cancerJPRN-UMIN000005087Showa University School of Medicine26
已完成
1 期
Phase I clinical trial of a mixed 20 peptides vaccine for castration-resistant prostate cancer (CRPC)JPRN-UMIN000008209Research Center for Innovative Cancer Therapy, Kurume University School of Medicine15